Historical MFN averages (2023); not current shipment rates. HS6 descriptions use the UN Comtrade Combined HS reference; the original rate nomenclature remains unconfirmed. National special codes require destination-specific verification. No effective date is available. The data review on September 11, 2026 does not update the rates. Reference source.
Chapter 30:
45 total items45 with duty rates0 headings
| HS Code | Description | Arabic | Duty Rate |
|---|---|---|---|
| 3001.20 | Glands and other organs; extracts of glands or other organs or of their secretions, for organo-therapeutic uses | 2.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3001.90 | Glands and other organs; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, n.e.c. in heading 3001 | 2.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3002.12 | Blood, human or animal, antisera, other blood fractions and immunological products; antisera and other blood fractions | 2.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3002.13 | Blood, human or animal, antisera, other blood fractions and immunological products; immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale | 2.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3002.14 | Blood, human or animal, antisera, other blood fractions and immunological products; immunological products, mixed, put up in measured doses or in forms or packings for retail sale | 2.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3002.15 | Blood, human or animal, antisera, other blood fractions and immunological products; immunological products, put up in measured doses or in forms or packings for retail sale | 2.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3002.41 | Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; for human medicine | 2.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3002.42 | Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; for veterinary medicine | 17.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3002.49 | Toxins, cultures of micro-organisms (excluding yeasts) and similar products; n.e.c. in item 3002.3 | 2.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3002.51 | Cell cultures, whether or not modified; cell therapy products | 2.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3002.59 | Cell cultures, whether or not modified; other cell cultures not including cell therapy products | 2.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3002.90 | Toxins, cultures of micro-organisms (excluding yeasts) and similar products | 2.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3003.10 | Medicaments; containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, (not in measured doses, not packaged for retail sale) | 10.00% (2023 MFN average; partial coverage)WITS 2023 historical MFN average · partial coverage | |
| 3003.20 | Medicaments; containing antibiotics other than penicillins, streptomycins and their derivatives, for therapeutic or prophylactic uses, (not in measured doses, not packaged for retail sale) | 10.00% (2023 MFN average)WITS 2023 historical MFN average | |
| 3003.31 | Medicaments; containing insulin, for therapeutic or prophylactic uses, not packaged for retail sale | 6.25% (2023 MFN average)WITS 2023 historical MFN average | |
| 3003.39 | Medicaments; containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale | 10.00% (2023 MFN average)WITS 2023 historical MFN average | |
| 3003.41 | Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, for therapeutic or prophylactic uses, (not packaged for retail sale) | 6.25% (2023 MFN average)WITS 2023 historical MFN average | |
| 3003.42 | Medicaments; containing alkaloids or their derivatives, containing pseudoephedrine (INN) or its salts, for therapeutic or prophylactic uses, (not packaged for retail sale) | 13.75% (2023 MFN average)WITS 2023 historical MFN average | |
| 3003.43 | Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, for therapeutic or prophylactic uses, (not packaged for retail sale) | 6.25% (2023 MFN average)WITS 2023 historical MFN average | |
| 3003.49 | Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts; for therapeutic or prophylactic uses, (not packaged for retail sale) | 10.00% (2023 MFN average)WITS 2023 historical MFN average | |
| 3003.60 | Medicaments; containing antimalarial active principles described in subheading note 2 to this chapter, for therapeutic or prophylactic uses, (not packaged for retail sale) | 10.00% (2023 MFN average)WITS 2023 historical MFN average | |
| 3003.90 | Medicaments; (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | 8.13% (2023 MFN average)WITS 2023 historical MFN average | |
| 3004.10 | Medicaments; containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | 13.75% (2023 MFN average)WITS 2023 historical MFN average | |
| 3004.20 | Medicaments; containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | 14.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3004.31 | Medicaments; containing insulin, for therapeutic or prophylactic uses, packaged for retail sale | 17.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3004.32 | Medicaments; containing corticosteroid hormones, their derivatives or structural analogues (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | 13.75% (2023 MFN average)WITS 2023 historical MFN average | |
| 3004.39 | Medicaments; containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | 14.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3004.41 | Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, for therapeutic or prophylactic uses, packaged for retail sale | 7.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3004.42 | Medicaments; containing alkaloids or their derivatives, containing pseudoephedrine (INN) or its salts, for therapeutic or prophylactic uses, packaged for retail sale | 13.75% (2023 MFN average)WITS 2023 historical MFN average | |
| 3004.43 | Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, for therapeutic or prophylactic uses, packaged for retail sale | 6.25% (2023 MFN average)WITS 2023 historical MFN average | |
| 3004.49 | Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts; for therapeutic or prophylactic uses, packaged for retail sale | 14.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3004.50 | Medicaments; containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | 15.63% (2023 MFN average)WITS 2023 historical MFN average | |
| 3004.60 | Medicaments; containing antimalarial active principles described in Subheading Note 2 to this Chapter, for therapeutic or prophylactic uses, packaged for retail sale | 17.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3004.90 | Medicaments; consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | 13.75% (2023 MFN average)WITS 2023 historical MFN average | |
| 3005.10 | Dressings, adhesive; and other articles having an adhesive layer, packed for retail sale for medical, surgical, dental or veterinary purposes | 25.00% (2023 MFN average)WITS 2023 historical MFN average | |
| 3005.90 | Wadding, gauze, bandages and similar articles; (excluding adhesive dressings), impregnated or coated with pharmaceutical substances, packaged for retail sale | 32.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3006.10 | Pharmaceutical goods; sterile surgical catgut, suture materials, tissue adhesives, laminaria, laminaria tents, absorbable surgical or dental haemostatics, and surgical or dental adhesion barriers | 27.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3006.30 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3006.40 | Pharmaceutical goods; dental cements and other dental fillings, bone reconstruction cements | 2.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3006.50 | Pharmaceutical goods; first aid boxes and kits | 2.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3006.60 | Pharmaceutical goods; chemical contraceptive preparations based on hormones, on other products of heading 2937 or on spermicides | 2.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3006.70 | Pharmaceutical goods; Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments | 2.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3006.91 | Pharmaceutical goods; appliances identifiable for ostomy use | 2.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3006.92 | Pharmaceutical goods; waste pharmaceuticals | 2.50% (2023 MFN average)WITS 2023 historical MFN average | |
| 3006.93 | Pharmaceutical goods; placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses | 2.50% (2023 MFN average)WITS 2023 historical MFN average |
Data source: WITS/UNCTAD TRAINS (MFN 2022). Values are indicative HS6 MFN averages, not shipment-specific applied rates. Import permission and restrictions are not assessed. Historical reference rates exclude VAT, excise and other national measures. Separate national entries preserve the columns printed by their source; these are not a complete shipment assessment. Full disclaimer.